Special considerations in pregnant systemic sclerosis patients

References

• Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003.
   PubMed Web of Science ®Google Scholar
• Sanges S, Guerrier T, Launay D, et al. Role of B cells in the pathogenesis of systemic sclerosis. Rev Med Interne. Forthcoming 2016.
   PubMedGoogle Scholar
• Meier FMP, Frommer KW, Dinser R, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012;71(8):1355–1360.
   PubMed Web of Science ®Google Scholar
• Silman AJ, Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis. 1988;47(6):441–444.
   PubMed Web of Science ®Google Scholar
• Steen VD, Conte C, Day N, et al. Pregnancy in women with systemic sclerosis. Arthritis Rheum. 1989;32(2):151–157.
   PubMed Web of Science ®Google Scholar
• Englert H, Brennan P, McNeil D, et al. Reproductive function prior to disease onset in women with scleroderma. J Rheumatol. 1992;19(10):1575–1579.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum. 1999;42(4):763–768.
   PubMed Web of Science ®Google Scholar
• Sampaio-Barros PD, Samara AM, Marques Neto JF. Gynaecologic history in systemic sclerosis. Clin Rheumatol. 2000;19(3):184–187.
   PubMed Web of Science ®Google Scholar
• Chung L, Flyckt RLR, Colón I, et al. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus. 2006;15(9):595–599.
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Khanna D, Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol. 2008;111(4):927–934.
   PubMed Web of Science ®Google Scholar
• Taraborelli M, Ramoni V, Brucato A, et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum. 1970–1977;64(6):2012.
   Google Scholar
• Chen JS, Roberts CL, Simpson JM, et al. Pregnancy outcomes in women with rare autoimmune diseases. Arthritis Rheumatol. 2015;67(12):3314–3323.
   PubMed Web of Science ®Google Scholar
• Bruni C, Raja J, Denton CP, et al. The clinical relevance of sexual dysfunction in systemic sclerosis. Autoimmun Rev. 2015;14(12):1111–1115.
   PubMed Web of Science ®Google Scholar
• Steen VD. Pregnancy in scleroderma. Rheum Dis Clin America. 2007;33(2):345–358.
   PubMed Web of Science ®Google Scholar
• Impens AJ, Rothman J, Schiopu E, et al. Sexual activity and functioning in female scleroderma patients. Clin Exp Rheumatol. 2009;27(3 Suppl 54):38–43.
   PubMedGoogle Scholar
• Harward L, Mitchell K, Pieper C, et al. The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease. Lupus. 2012;22(1):81–86.
   Web of Science ®Google Scholar
• Ibba-Manneschi L, Manetti M, Milia AF, et al. Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. Ann Rheum Dis. 2010;69(2):458–461.
   PubMed Web of Science ®Google Scholar
• Papakonstantinou K, Hasiakos D, Kondi-Paphiti A. Clinicopathology of maternal scleroderma. Int J Gynecol Obstetrics. 2007;99(3):248–249.
   PubMed Web of Science ®Google Scholar
• Doss BJ, Jacques SM, Mayes MD, et al. Maternal scleroderma: placental findings and perinatal outcome. Hum Pathol. 1998;29(12):1524–1530.
   PubMed Web of Science ®Google Scholar
• Steen VD. Pregnancy in women with systemic sclerosis. Obstet Gynecol. 1999;94(1):15–20.
   PubMed Web of Science ®Google Scholar
• Van Wyk L, Van Der Marel J, Schuerwegh AJ, et al. Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study. Arthritis Res Ther. 2011;13(6):R183.
   Google Scholar
• Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ (Clinical Research Ed.). 2000;320(7251):1708–1712.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus. Ann Intern Med. 2015;163(3):153–15.
   PubMed Web of Science ®Google Scholar
• Silversides CK, Colman JM. Physiological changes in pregnancy. In: Oakley C, Warnes CA, editors. Heart disease in pregnancy. 2nd ed. Malden (MA): Blackwell; 2007.
   Google Scholar
• Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstetrics Gynaecol. 2008;22(5):801–823.
   PubMed Web of Science ®Google Scholar
• Gazioglu K, Kaltreider NL, Rosen M, et al. Pulmonary function during pregnancy in normal women and in patients with cardiopulmonary disease. Thorax. 1970;25(4):445–450.
   PubMed Web of Science ®Google Scholar
• Zavorsky GS, Blood AB, Power GG, et al. CO and NO pulmonary diffusing capacity during pregnancy: safety and diagnostic potential. Respir Physiol Neurobiol. 2010;170(3):215–225.
   PubMed Web of Science ®Google Scholar
• Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211–215.
   PubMed Web of Science ®Google Scholar
• Steen VD, Syzd A, Johnson JP, et al. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol. 2005;32(4):649–655.
   PubMed Web of Science ®Google Scholar
• Denton CP, Lapadula G, Mouthon L, et al. Renal complications and scleroderma renal crisis. Rheumatology (Oxford, England). 2009;48(Suppl 3):iii32–5.
   PubMedGoogle Scholar
• Hudson M, Baron M, Tatibouet S, et al. International Scleroderma Renal Crisis Study Investigators. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey. Semin Arthritis Rheum. 2014;43(5):666–672.
   PubMed Web of Science ®Google Scholar
• Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstetrics Gynecol Reprod Biol. 2013;170(1):1–7.
   PubMed Web of Science ®Google Scholar
• Piccoli GB, Daidola G, Attini R, et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. BJOG: Int J Obs Gyn. 2013;120(4):412–427.
   PubMed Web of Science ®Google Scholar
• Day C, Hewins P, Hildebrand S, et al. The role of renal biopsy in women with kidney disease identified in pregnancy. Nephrol Dial, Transpl: Off Publ Eur Dial Transpl Assoc Eur Ren Assoc. 2008;23(1):201–206.
   PubMed Web of Science ®Google Scholar
• Lidar M, Langevitz P. Pregnancy issues in scleroderma. Autoimmun Rev. 2012;11(6–7):A515–9.
   PubMed Web of Science ®Google Scholar
• Launay D, Hebbar M, Valat AS, et al. Systemic sclerosis and pregnancy. Rev Med Interne. 2002;23(7):607–621.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1: PlGFRatio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22.
   PubMed Web of Science ®Google Scholar
• Soh MC, Nelson-Piercy C. High-risk pregnancy and the rheumatologist. Rheumatology. 2015;54(4):572–587.
   PubMed Web of Science ®Google Scholar
• Lapinsky SE, Tram C, Mehta S, et al. Restrictive lung disease in pregnancy. Chest. 2014;145(2):394–398.
   PubMed Web of Science ®Google Scholar
• Boggess KA, Easterling TR, Raghu G. Management and outcome of pregnant women with interstitial and restrictive lung disease. Am J Obstet Gynecol. 1995;173(4):1007–1014.
   PubMed Web of Science ®Google Scholar
• Lewey J, Haythe J. Cardiomyopathy in pregnancy. Semin Perinatol. 2014;38(5):309–317.
   PubMed Web of Science ®Google Scholar
• Sobanski V, Launay D, Hachulla E, et al. Current approaches to the treatment of systemic-sclerosis-associated pulmonary arterial hypertension (SSc-PAH). Curr Rheumatol Rep. 2016;18(2):10–14.
   PubMed Web of Science ®Google Scholar
• Lefèvre G, Dauchet L, Hachulla E, et al. Survival and prognostic factors in systemic sclerosis–associated pulmonary hypertension: a systematic review and meta‐analysis. Arthritis Rheum. 2013;65(9):2412–2423.
   PubMed Web of Science ®Google Scholar
• Sobanski V, Giovannelli J, Lynch BM, et al. Characteristics and survival of anti-u1 rnp antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheumatol. 2016;68(2):484–493.
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–975.
   PubMed Web of Science ®Google Scholar
• Jaïs X, Olsson KM, Barberà JA, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 2012;40(4):881–885.
   PubMed Web of Science ®Google Scholar
• Brucato A, Cimaz R, Caporali R, et al. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol. 2011;40(1):27–41.
   PubMed Web of Science ®Google Scholar
• De León Aguirre AR, Calvo JAR, Reyna TSR. Comprehensive approach to systemic sclerosis patients during pregnancy. Reumatología Clínica (English Edition). 2015;11(2):99–107.
   Google Scholar
• Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795–810.
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA. Long-term outcomes of scleroderma renal crisis. Ann Intern Med. 2000;133(8):600–603.
   PubMed Web of Science ®Google Scholar
• Downloads | Systemic sclerosis | Published Guidelines | Rare Diseases [Internet]. orphananesthesia.eu. Available from: http://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/cat_view/61-rare-diseases/60-published-guidelines/143-systemic-sclerosis.html.
   Google Scholar
• Roberts JG, Sabar R, Gianoli JA, et al. Progressive systemic sclerosis: clinical manifestations and anesthetic considerations. J Clin Anesth. 2002;14(6):474–477.
   PubMed Web of Science ®Google Scholar
• Bernard N, Jantzem H, Becker M, et al. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey. BJOG: Int J Obs Gyn. 2015;122(9):1244–1251.
   PubMed Web of Science ®Google Scholar